Skip to main content

Table 1 Demographics and Baseline Characteristics (intent-to-treat population)

From: Combined fluticasone furoate/vilanterol reduces decline in lung function following inhaled allergen 23 h after dosing in adult asthma: a randomised, controlled trial

Demographics (N = 52a)

Age, mean (SD)

35.4 (8.63)

Female, %

35

BMI, kg/m 2 , mean (range)

25.94 (18.9–33.6)

White race, %

92

Lung function

Pre-bronchodilator FEV 1 , L, mean (SD)

3.52 (0.713)

Pre-bronchodilator FEV 1 % Pred., mean (SD)

89.71 (8.848)

  1. a51 subjects took part in each of the treatment periods. BMI = body mass index; FEV1 = forced expiratory volume in 1 s; L = litres; SD = standard deviation.